Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Remuneration Reductions & Distribution Commitment

9 Oct 2025 07:00

RNS Number : 6429C
Tern PLC
09 October 2025
 

9 October 2025

 

Tern Plc

 

("Tern" or the "Company")

 

Reductions in Board and Executive Management Fixed Remuneration and Distribution Commitment

 

Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, announces a reduction in the fixed remuneration of Tern's board (the "Board") and its executive management, together with a distribution commitment for when significant proceeds are received from exits of the Company's investments.

 

As previously announced, the focus of the Board and Tern's executive management team is on realisations and specifically seeking to maximise the value that can be realised from Tern's portfolio companies and investments through successful exits from its investments at the appropriate time, ultimately seeking strong returns for shareholders. At the same time the Company is maintaining strict control over operational costs and looking to make further savings where appropriate, in addition to the significant savings made in 2024 and the current financial year.

 

The Board have examined ways in which the operational costs of the Company can be further reduced, whilst aligning the interests of Tern's Board and executive management with those of shareholders. The Board, with the agreement of the executive management, have therefore resolved that:

 

· Fixed remuneration reduction: From 1 November 2025 there will be a 50 per cent reduction in the salaries of the two Board directors, Jane McCracken and Iain Ross, and Tern's executive managers Al Sisto and Bruce Leith. This is expected to provide a saving of approximately £153,000 on an annualised basis.

· Performance-aligned remuneration policy: The Board has adopted a remuneration policy whereby 12.5% of the net proceeds of any exit of the Company's investments will be allocated to the executive team and Board, being those directly responsible for the Company's capital allocation, strategy, and execution.

· Shareholder distribution commitment: The Board has committed that shareholders will receive a distribution or capital return of at least 50% of the net proceeds received by the Company from the exit of any individual investment over £1 million (subject to the Company having sufficient distributable reserves and no legal or regulatory impediment to undertaking such an action).

 

Commenting, Jane McCracken, Interim Non-Executive Chair of Tern, said: "We recognise that it is very important that management and shareholder interests are aligned, particularly during this capital-intensive phase of development of Tern's investments. The decision to reduce Board and executive management salaries by 50% will only have a modest financial impact on Tern, but coupling this with a fixed performance-based component of remuneration reflects our desire to signal a clear alignment of interests with shareholders.  This is not a discretionary bonus scheme, but a lean, outcome-driven policy designed to reflect the team's scale of responsibility and the nature of our mandate.

 

"Our focus remains on realisations and we wish to give shareholders a clearer indication of what they can expect when we receive proceeds from exiting investments. The Tern Board and management team are all working hard to deliver shareholder value and I look forward to providing further updates in due course."

 

Enquiries

 

Tern Plc

Jane McCracken (Interim Non-Executive Chair)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Dan Dearden-Williams (Corporate Finance)

Kelly Gardiner / Guy McDougall (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Staton

 

Tel: 0203 934 6630

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKZMGGLRKGKZM
Date   Source Headline
16th Dec 20247:01 amRNS-ROnline Investor Presentation and Q&A Session
16th Dec 20247:00 amRNSPlacing to raise £400,000
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSBoard Changes
25th Oct 20248:27 amRNSFurther re. Wyld Networks Rights Issue
15th Oct 20247:00 amRNSPlacing to raise £625,000
30th Sep 20245:04 pmRNSTotal Voting Rights
30th Sep 20247:00 amRNSDevice Authority Update
23rd Sep 202411:13 amRNSReplacement: Results of Open Offer
23rd Sep 202411:10 amRNSResult of General Meeting
23rd Sep 20247:00 amRNSResults of Open Offer
5th Sep 20247:00 amRNSOpen Offer and Notice of General Meeting
5th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
2nd Sep 202410:16 amRNSStatement re Wyld Networks Rights Issue
9th Aug 20247:00 amRNSPartial sale of Device Authority holding
27th Jun 202412:00 pmRNSResult of AGM
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResults for the year ended 31 December 2023
15th May 20247:00 amRNSExercise of Warrants
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility
31st May 20237:00 amRNSResults for the year ended 31 December 2022
26th May 20237:00 amRNSKonektio Fundraise

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.